Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166 (Q77324254)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

1 reference

Kouji Oba

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Hiroyuki Konno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Tatsuo Tanaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Megumi Baba

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Kinji Kamiya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Manabu Ohta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Takeshi Kaneko

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Tsuyoshi Shouji

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Akira Igarashi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Satoshi Nakamura

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

45-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Development of matrix metalloproteinase inhibitors in cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Metalloproteinases and their inhibitors in matrix remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900726-1

7 January 2021

10.1016/S0304-3835(01)00726-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11734335%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference